BIAF · Company research
bioAffinity Technologies, Inc. (BIAF): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A test of lung cells gives doctors a “likely” or “unlikely” cancer-risk result. - Stock Titan | A test of lung cells gives doctors a “likely” or “unlikely” cancer-risk result. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance UK | bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| bioAffinity Technologies, Inc. (BIAF) Stock Price, News, Quote & History - Yahoo! Finance Canada | bioAffinity Technologies, Inc. (BIAF) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 14, 2026 | neutral | 0 | 0.6 |
| A test in development found multiple lung-inflammation markers in mucus. bioAffinity will present the research. - Stock Titan | A test in development found multiple lung-inflammation markers in mucus. bioAffinity will present the research. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Stockholders face dilution under bioAffinity (BIAF)'s proposed discounted non-public offerings. - Stock Titan | Stockholders face dilution under bioAffinity (BIAF)'s proposed discounted non-public offerings. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| bioAffinity Technologies Completes New $4 Million Financing - The Globe and Mail | bioAffinity Technologies Completes New $4 Million Financing The Globe and Mail | View source ↗ | The Globe and Mail | Oct 10, 2026 | neutral | 0 | 0.6 |
| BIAF Stock Slides As Traders Weigh Heavy Losses And Volatility - Timothy Sykes | BIAF Stock Slides As Traders Weigh Heavy Losses And Volatility Timothy Sykes | View source ↗ | Timothy Sykes | Oct 8, 2026 | neutral | 0 | 0.6 |
| BIAF Stock Slides As BioAffinity Momentum Cools Off - StocksToTrade | BIAF Stock Slides As BioAffinity Momentum Cools Off StocksToTrade | View source ↗ | StocksToTrade | Oct 8, 2026 | neutral | 0 | 0.6 |
| Biotech Stock bioAffinity Technologies (Nasdaq: BIAF) Soars on Japanese Patent Allowance - Investorideas.com | Biotech Stock bioAffinity Technologies (Nasdaq: BIAF) Soars on Japanese Patent Allowance Investorideas.com | View source ↗ | Investorideas.com | Oct 8, 2026 | neutral | 0 | 0.6 |
| A company behind a lung cancer test expects about $4 million; net proceeds are intended to support expected sales growth. - Stock Titan | A company behind a lung cancer test expects about $4 million; net proceeds are intended to support expected sales growth. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| BIAF Stock Draws Traders As CyPath Lung Growth Accelerates - StocksToTrade | BIAF Stock Draws Traders As CyPath Lung Growth Accelerates StocksToTrade | View source ↗ | StocksToTrade | Oct 8, 2026 | neutral | 0 | 0.6 |
| BIAF Stock Draws Traders As CyPath Lung Growth Accelerates - Timothy Sykes | BIAF Stock Draws Traders As CyPath Lung Growth Accelerates Timothy Sykes | View source ↗ | Timothy Sykes | Oct 8, 2026 | neutral | 0 | 0.6 |
| Japan intends to grant a patent for a home-collected lung cancer risk test - Stock Titan | Japan intends to grant a patent for a home-collected lung cancer risk test Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance Singapore | bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 7, 2026 | neutral | 0 | 0.6 |
| More than 1,620 tests to assess lung cancer risk were delivered through Q3 2026. - Stock Titan | More than 1,620 tests to assess lung cancer risk were delivered through Q3 2026. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance Australia | bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 1, 2026 | neutral | 0 | 0.6 |
| BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart - ChartMill | BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart ChartMill | View source ↗ | ChartMill | Sep 24, 2026 | neutral | 0 | 0.6 |
| BIAF stock jumps on Hong Kong patent news, with recent low-float dynamics likely adding to volatility - Quiver Quantitative | BIAF stock jumps on Hong Kong patent news, with recent low-float dynamics likely adding to volatility Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 17, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.